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Abstract 
Background: Three equine influenza viruses, A/equine/Nador/1/1997(H3N8), A/equine/Essaouira/2/2004(H3N8), and 
A/equine/Essaouira/3/2004(H3N8), were isolated from different Equidae during local respiratory disease outbreaks in 
Morocco in 1997 and 2004. Their non-structural (NS) genes were amplified and sequenced.
Results: The results show high homology of NS nucleotide sequences of A/equine/Nador/1/1997 with European 
strains (i.e., A/equine/newmarket/2/93 and A/equine/Grobois/1/1998) and clustered into the European lineage. 
However, NS gene of A/equine/Essaouira/2/2004(H3N8) and A/equine/Essaouira/3/2004(H3N8) strains indicated high 
homology with equine influenza strains that had circulated before 1990 (A/equine/Fontainbleu/1/1979(H3N8), which 
belonged to a pre-divergent phase Amino acid sequence comparison of the NS1 protein with reference strain A/
equine/Miami/1963(H3N8) shows that the A/equine/Nador/1/1997(H3N8) strain has 12 substitutions at the residues 
D/24/N, R/44/K, S/48/I, R/67/Q, A/86/V, E/139/K, A/112/T, E/186/K, L/185/F, A/223/E, S/213/T and S/228/P. In both A/
equine/Essaouira/2/2004(H3N8) and A/equine/Essaouira/3/2004(H3N8) strains, the NS1 sequences present one com-
mon mutation at the residue: S/228/P.
Conclusion: It seems that all of these substitutions are not produced at the key residues of the RNA-binding domain 
(RBD) and the effector domain (ED). Consequently, we can suppose that they will not affect the potency of inhibition 
of cellular defences, and the virulence of the Moroccan equine strains will be maintained.
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Background
Equine influenza virus is a highly contagious agent, capa-
ble of causing explosive outbreaks of respiratory disease 
among susceptible horse populations in many coun-
tries [1]. Two distinct subtypes of influenza virus, H7N7 
(prototype influenza A/equine/Prague/1/56) and H3N8 
(prototype influenza A/equine/Miami/1/63), have been 
recognized in the horse [2, 3]. The first subtype (H7N7) 
is believed to be extinct and has not been isolated in the 
horse since 1979. The other subtype (H3N8) was isolated 
for the first time in 1963 and was responsible for all recent 
equine influenza outbreaks [4, 5]. These viruses belong to 
the Orthomyxoviridae family type A. The genome com-
prises eight segments of RNA [6]. These segments are 
encapsulated by a nucleoprotein (NP), which gives a heli-
cal symmetry to each. Six segments encode one protein: 
hemagglutinin (HA), neuraminidase (NA), nucleoprotein 
(NP), and three polymerases: PA, PB1, and PB2. Each of 
the other segments encodes two proteins: the matrix (M1 
and M2) and a non-structural protein (NS1) and NS2 
(NEP: nuclear export). The genomes of several virulent 
strains encode an 11th protein PB1-F2 [7]. NS1, NS2, and 
PB1-F2 proteins participate in viral replication and are 
not incorporated into the viral structure.
The presence of double-stranded RNA (dsRNA) is a 
signal of a viral infection, causing the activation of the 
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cellular defence system through the synthesis of the inter-
feron protein (IFN) [8]. However, influenza viruses have 
developed a strategy to antagonize the cellular defences. 
The non-structural protein NS1 is regarded as the major 
antagonist of the immune response of the host cells [9]. 
In most viruses, the NS1 protein consists of 230 amino 
acids (aa) and the NEP protein of 121 aa [10]. However, 
a size variability of the NS1 protein was observed, espe-
cially in the human and swine viruses [11]. In the case 
of H3N8 equine influenza virus, truncations have been 
shown as well as other influenza viruses [12, 13].
The linear structure of the NS1 protein contains two 
domains linked by a non-structured region composed 
of ten amino-acids: The first one is the RNA-binding 
domain (RBD), representing the N-terminal protein 
(amino acids 1–73), the second is an effector domain 
(ED), which represents C-terminal protein (amino acids 
74–230) [14].
The RNA-binding domain has an alpha-helical struc-
ture and forms a symmetrical homo-dimer with a unique 
six-helical chain fold. The effector domain forms a dimer, 
and each monomer consists of seven beta-strands and 
three alpha helices [15]. The non-structural protein NS1 
contains several interaction domains: the region of bind-
ing to dsRNA (residues 1–73), the specific cleavage and 
polyadenylation specific factor region (CPSF) (residues 
175–210), the region of the binding protein (PABP)—
II (poly (A)—binding protein—II) (residues 218–225), 
the region of nuclear localization signal 1 (NLS 1) (resi-
dues 34–38), the region nuclear localization signal 2 
(NLS 2: nuclear localization signal) (residues 211–216), 
the region of the nuclear export signal (NES) (residues 
132–141), and the region that interacts with subunit 
regulatory p85-β of phosphatidylinositol 3-kinase (PI3K) 
(residues 89–93, 137–142 and 164–167) [16].
The PDZ domain binding is present at the C-termi-
nal of NS1 among equine influenza viruses (H3N8) 
(sequence ESEV/EPEV), and it is known as a determinant 
of viral virulence.
In the present study, we report analysis of the partial 
nucleotide sequence of the NS gene and the NS1 protein 
for three Moroccan equine influenza viruses: A/Equine/
Nador/1/97, A/Equine/Essaouira/2/2004, and A/Equine/
Essaouira/3/2004, and their genetic comparison with 
influenza strains (human, equine, swine, avian) available 
in the GenBank database.
Methods
Viruses
A/equine/Nador/1/97 was isolated in Nador from a mule 
after four passages on eleven -day-old embryonated spe-
cific pathogen-free chicken eggs (ECE4) as described by 
Kissi et  al. (1998) [17]. Both A/equine/Essaouira/2/2004 
and A/equine/Essaouira/3/2004 were isolated respec-
tively from an infected donkey and a horse during 2004 
outbreaks in Essaouira. The isolates were passaged on 
Madin Darby Canine Kidney cell line after two passages 
(MDCK2) at 34 °C in an atmosphere of 5 % CO2 in Eagle’s 
minimum essential media supplemented with 5 % foetal 
calf serum.
Viral RNA extraction and amplification
Viral RNA was extracted directly from isolates using a 
PureLink Viral RNA/DNA Mini-Kit (Invitrogen, Van 
Allen Way, Carlsbad, California, USA) following the 
manufacturer’s recommended protocol. Complementary 
DNA was obtained by RT reactions, which were carried 
out by using a SuperScript III First-Strand Synthesis Sys-
tem (Life Technologies, Carlsbad, CA, USA).
PCR was performed using a Platinum PCR Super-
Mix High-Fidelity Kit (Invitrogen, Carlsbad, CA, 
USA) with cDNA obtained using primers specific for 
NS1F (ATGGATTCCAACACTGTGTC) and NS1R 
(TCAAACTTCTG(A/G)CTCAATTG) at a final concen-
tration of 0.5  µM for primers. Primer design is detailed 
by Tissier (2008) [18] and was synthesized by the Unité 
d’Appui Technique à la Recherche Scientifique, Cen-
tre National de Recherche Scientifique et Technique 
(CNRST), Rabat, Morocco. The assay was performed on 
the SmartCycler instrument (Cepheid, Sunnyvale, CA, 
USA), using the following thermocycling protocol: incu-
bation at 95 °C for 2 min, then 35 cycles of denaturation 
at 95  °C for 30 s, 52  °C for 1 min for hybridization, and 
72 °C for 30 s, and a final extension for 3 min at 72 °C.
Sequencing NS Genes and phylogenetic Analysis
The amplified PCR NS products were sequenced. 
Briefly, the PCR products were purified using EXOSAP-
IT (USB Corporation, Cleveland, OH, USA) and bi-
directionally sequenced by using BigDye1 Terminator 
v3.1 (Applied Biosystems, Foster City, Calif. USA) on a 
3130xl model sequencer (Applied Biosystems). Analy-
sis of the electro-phoregramm was carried out with 
the sequencing analysis software version 5.3.1 (Applied 
Biosystems). We performed phylogenetic analysis of 54 
influenza strains (including equine, avian and human 
isolates) published in GenBank database, selected using 
the neighbour-joining method with bootstrap analyses 
of 500 replicates in CLUSTAL W. The tree was visual-
ized using MEGA5.1 software (http://megasoftware.
net/) [19].
Determination of amino acid sequences of NS genes
Multiple alignments of the deduced amino acid 
sequences were used by Basic Local Alignment Search 
Tool (BLAST) software. Comparing NS1 protein of 
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Moroccan isolates to the reference strain (A/Equine/
Miami/1/1963), the amino acid substitutions that were 
involved in both RNA-binding domain (RBD) and effector 
domain (ED) were determined.
Results and discussion
Partial NS nucleotide sequences of the Moroccan equine 
influenza isolates (A/equine/Nador/1/1997, A/equine/
Essaouira/2/2004, and A/equine/Essaouira/3/2004) were 
submitted to the GenBank database, and their acces-
sion numbers of NS genes are JX182368, JQ955611, and 
JQ955614, respectively.
BLAST results
The BLAST result shows that the nucleotide sequences 
of the NS gene of two strains A/equine/Essaouira/2/2004 
and A/equine/Essaouira/3/2004 presents high simi-
larity between them, and towards other old strains 
like A/equine/Miami/1/1963 (>99  %), A/equine/Uru-
guay/1/63(99  %), A/eq/LaPlata/1/88 (>99  %), and A/
equine/Fontainebleau/79 (98  %). These strains have cir-
culated before 1990. Since then, the equine influenza 
viruses have diverged into two antigenically distinct 
lineages, Eurasian and American. According to several 
authors, the pre-divergent strains have disappeared and 
were supplanted by viruses that evolved in lineages and 
sub-lineages [20].
The partial nucleotide sequence of the NS gene of A/
equine/Nador/1/97 strain is genetically distant towards 
the pre-divergent strains. Indeed, it demonstrates high 
homology to the strains that have circulated in Europe 
during the 1990s, i.e., A/equine/Newmarket/2/1993 
(99  %), A/equine/Avesta/1/1993 (99  %), A/equine/
Grobois/1/98 (98  %), A/equine/Italy/1199/1992 (98  %), 
and A/equine/Roma/5/1991 (98 %).
Phylogenetic analysis
Data obtained from BLAST was confirmed by the phy-
logenetic analysis based on 54 nucleotide sequences 
of the NS gene of influenza A viruses, which were iso-
lated from various species (human, avian, swine, and 
equine). The NS genes of the Moroccan strains are clus-
tered into a lineage of the equine influenza virus (H3N8) 
that belongs to the A allele. The two strains, A/equine/
Essaouira/2/2004 and A/equine/Essaouira/3/2004, 
belong to the pre-divergent phase, while the A/equine/
Nador/1/97 belongs to the Eurasian lineage (Fig.  1). 
Moreover, the sequencing analysis of the HA (accession 
numbers JQ955607, JQ955609, and JQ955612) of A/
equine/Nador/1/1997, A/equine/Essaouira/2/2004, and 
A/equine/Essaouira/3/2004, respectively) revealed same 
data. Such results show that these three strains isolated 
in Morocco share the same ancestors as the equine influ-
enza (H3N8) virus and that there was no genetic reas-
sortment between co-circulating strains in Morocco [21].
The data matrix containing 54 taxa and phylogenetic 
analyses were deposited into TreeBase under acces-
sion url: http://purl.org/phylo/treebase/phylows/study/
TB2:S18066.
Comparison analysis of amino acids alignment
Compared to the reference strain A/equine/
Miami/1/1963, the sequences of amino acids of the NS1 
protein of the strain A/equine/Nador/1/1997 have 12 
substitutions: D/24/N, R/44/K, S/48/I, R/67/Q, A/86/V, 
E/139/K, A/112/T, E/186/K, L/185/F, A/223/E. S/213/T, 
and S/228/P. These mutations occurred in both RNA-
binding and effector domains (Fig. 2).
The D/24/N substitution occurred in a changing region 
of the RBD (19 to 28) of the NS1 protein of influenza 
viruses [22]. This mutation may not affect the structure of 
(See figure on next page.) 
Fig. 1 Phylogenetic analysis of the partial nucleotide sequences of NS of 54 strains (human, avian, swine and equine). A/Aichi/2/1968(H3N2), 
M34829; A/Alaska/6/1977(H3N2), K01332; A/AnnArbor/6/1960(H2N2), M23968; A/Beijing/32/1992(H3N2), D30667; A/Berkeley/1/1968(H2N2), 
M12590; A/Canterbury/02/2005(H3N2), CY007807; A/FortWarren/1/1950(H1N1), K00576; A/Houston/18515/1984(H1N1), M12594; A/
Houston/24269/1985(H3N2), M17699; A/Kitakyushu/159/93(H3N2), D30676; A/Leningrad/134/17/1957(H2N2), M81578; A/Maryland/2/1980(H1N1), 
M12595; A/NewYork/191/2005(H3N2), CY006127; A/USSR/90/1977(H1N1), K00578; A/Adorn/8/1972(H3N2), V01102; A/chicken/Germany/
N/1949(H10N7), AF001407; A/duck/Alberta/60/1976(H12N5), J02105; A/eq/LaPlata/93(H3N8), AF001673; A/equine/Avesta/1/1993(H3N8), 
AB543512; A/equine/Detroit/3/1964(H7N7), M80970; A/equine/Essaouira/2/2004(H3N8), JQ955611; A/equine/Essaouira/3/2004(H3N8), 
JQ955614; A/equine/Fontainbleu/1/1979(H3N8), CY032409; A/equine/Grobois/1/1998(H3N8), AY328471; A/equine/Italy/1062/1991(H3N8), 
CY032377; A/equine/Jilin/1/1989(H3N8), M65020; A/equine/Miami/1/1963(H3N8), CY028840; A/equine/Nador/1/1997(H3N8), JX182368; A/
equine/Newmarket/2/1993(H3N8), FJ375211; A/equine/Ohio/1/2003(H3N8), DQ124186; A/equine/Prague/1/1956(H7N7), M80944; A/equine/
Richmond/2/2007(H3N8), FJ195442; A/equine/Rome/5/1991(H3N8), AF001669; A/equine/Uruguay/1/1963(H3N8), CY032425; A/equine/
Yvelines/2136/1989(H3N8), AF001666; A/goose/Guangdong/3/1997(H5N1), AY028445; A/gull/Maryland/19/1977(H2N9), CY005810; A/gull/
Maryland/704/1977(H13N6), M80959; A/gull/Massachusetts/26/1980(H13N6), U96744; A/gull/Minnesota/945/1980(H13N6), U96738; A/laughing 
gull/Delaware Bay/2838/1987(H13N2), CY005068; A/mallard/New York/6750/1978(H2N2), M80945; A/mallard/NewYork/6874/1978(H3N2), M25375; 
A/mallard/Wisconsin/428/1975(H5N1), U85380; A/pintail/Alberta/119/1979(H4N6), M25374; A/ruddy turnstone/New Jersey/47/1985(H4N6), 
M80946; A/swine/1976/1931(H1N1), M55482; A/swine/Hokkaido/2/1981(H1N1), M80961; A/swine/Iowa/15/1930(H1N1), M80965; A/swine/
Wisconsin/1/1961(H1N1), M80951; A/tern/Turkmen/18/1972(H3N3), M55466; A/turkey/Minnesota/10734/1995(H5N2), U85391; A/turkey/
Ontario/7732/1966(H5N9), U85376; A/turkey/Oregon/1971(H7N3), M16623. Numbers next to nodes indicate bootstrap value percentages (>90 %)
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the NS1 protein RNA binding domain or its activity. This 
finding is confirmed by the virulence of the A/equine/
Nador/1/1997 strain, which caused severe respiratory 
signs among naturally infected mules. The same substitu-
tion was also reported by Parveen and Asad (2010) [23] 
concerning the human strain A/North Dakota/04/2009 
(H1N1) (ACR67137).
The three mutations (R/44/K, S/48/I, and R/67/Q) 
revealed on the RBD do not seem to affect virulence, 
because they do not concern the following residues: Thr-
5, Pro-31, Asp-34, Arg-35, Arg-38, Lys-41, Gly-45, Arg-46, 
and Thr-49, which are closely linked to the activity of the 
NS1 protein. Several authors have reported that these nine 
amino acids are the key residues of RBD activity [9, 10, 24].
Mutations that occurred on the effector domain were 
reported in several sites recognized as having functional 
roles. In fact, mutations at residues A/86/V and A/112/T 
occurred in a specific region of the eIF4GI protein (81 to 
113), and they participate with the protein PABPI in the 
initiation of mRNA viral translation [25, 26].
The binding of the protein CPSF30 (cleavage and poly-
adenylation specific factor) inhibits the maturation of 
Fig. 2 Amino acid alignment of 25 predicted NS sequences compared to A/equine/Miami/1963. A/equine/Miami/1/1963, ABY81497; A/equine/
Nador/1/1997, AFN69204; A/equine/Essaouira/2/2004, AFJ69907; A/equine/Essaouira/3/2004, AFJ69911; A/eq/LaPlata/93, AAC31270; A/equine/
Aboyne/1/2005, ACH95651; A/equine/Ahmedabad/1/2009, ADB45168; A/equine/Almaty/26/2007, ADE21678; A/equine/Austria/421/1992, ACD85324; 
A/equine/California/4537/1997, ACA96805; A/equine/Cheshire/1/2007, ACH95645; A/equine/Grobois/1/1998, AAP92165; A/equine/Italy/1199/1992, 
ACD85313; A/equine/Kentucky/2/1980, ACF22120; A/equine/Kentucky/7/2007, ACH95629; A/equine/Newmarket/1/2007, ACH95607; A/equine/North 
Carolina/152429/2002, ACZ47169; A/equine/Ohio/1/2003, ABA42431; A/equine/Pulawy/1/2005, AIW60784; A/equine/Xuzhou/01/2013, AHA98359; 
A/eq/Kentucky/92, AAC31266; A/equine/Cheshire/1/2006, ACH95605; A/equine/Kentucky/1/1997, ACH95653; A/equine/Lincolnshire/1/2006, 
ACH95599; A/equine/Yvelines/2136/1989, AAC31256. Topology of α-helix and β-strands of NS1 protein: α1(4–24), α2 (31–50), α3 (54–70), α4(95–99), 
α5(171–188), α6 (195–205), β1(88–91), β2 (107–112), β3 (115–120), β4(126–136), β5(142–151), β6 (157–162), β7 (191–194) [15]
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cellular pre-mRNA. This link is provided by amino acids 
144, 184, and 188 (186 region) [15, 27]. It appears that 
both L/185/F and E/186/K mutations may not reduce the 
affinity of NS1 to CPSF30 protein, and consequently do 
not inhibit viral replication.
Three substitutions, E/139/K, S/213/T, and A/223/E, 
were reported in domain activity of nucleocytoplasmic 
distribution in the cell of the NS1 protein. The E/139/K 
mutation is located at the nuclear export signal region 
(NES: nuclear export signal) (residues 132–141) [16]. 
Furthermore, similar mutations at this residue were also 
observed for the NS1 of the following strains: N/139/E 
(A/equine/North Carolina/152429/2002, ACZ47169); 
and E/139/A (A/equine/Xuzhou/01/2013, AHA98359) 
(Fig.  2). The two mutations, S/213/T and A/223/E, 
occurred at nuclear localization signal (NLS2) and PAB-
PII domains, respectively. NLS2 is defined within the 
region between amino acids 213 and 221. This domain 
is present in the NS1 proteins of most influenza A virus 
strains. However, several substitutions affecting it were 
noticed, such as: S/213/T (i.e.,: A/equine/Nador/1/1997, 
AFN69204 and A/equine/Aboyne/1/2005, ACH95651), 
and P/214/S (i.e.,: A/equine/Cheshire/1/2007, 
ACH95645). However, nuclear localization signal 1 
(NLS1) contains the stretch of basic amino acids Asp-
Arg-Leu-Arg-Arg (codons 34 to 38). This sequence is 
conserved in three Moroccan strains as all NS1 proteins 
of influenza A viruses [28]. It appears that the substitu-
tion occurred in NLS2 do not seem to interfere with the 
nuclear localization of NS1 protein; because the intracel-
lular localization is regulated by one or two nuclear local-
ization signals (NLS) and a nuclear export signal (NES) 
[29].
Multiple comparisons of the NS1 protein of 27 equine 
influenza viruses show that the mutations D/24/N and 
E/139/K characterize the A/equine/Nador/1/1997(H3N8) 
strain, while the A/86/V and S/213/T mutations are 
shared with several European lineage strains. However, 
the eight substitutions (R/44/K, S/48/I, R/67/Q, A/112/T, 
E/186/K, L/185/F, A/223/E, and S/228/P) are present in 
various equine influenza viruses (H3N8) belonging to dif-
ferent phases of evolution (pre-divergence and the Amer-
ican and European lineages) (Table 1).
The NS1 protein of both strains of Essaouira presents 
an identical sequence of them. Therefore, compared to 
reference strain A/equine/Miami/1/1963, the carboxyl 
terminus of the NS1 proteins shows a common mutations 
regarding substitution S/228/P. Moreover, the PDZ-bind-
ing sequence, Glu-Pro-Glu-Val (EPEV) motif appears in 
both avian as well as swine, human and equine viruses.
In addition, the presence of the EPEV sequence in 
the NS1 protein of three equine Moroccan strains is an 
indicator of virulence [30]. This sequence, present at the 
C-terminus of NS1 of the H5N1 virus (sequence ESEV/
EPEV) and the H1N1 pandemic of 1918 (sequence KSEV) 
but absent among seasonal human viruses, establishes 
binding with the PDZ domains [31]. The ESEV sequence 
is common among avian viruses. Its presence in NS1 of 
the A/equine/Miami/1/1963(H3N8) strain is related 
to its ancestral avian virus, which infected horses of 
North America in 1963 [32], while the S/228/P mutation 
observed in the three Moroccan strains is considered to 
be an adaptation of avian influenza viruses (H3N8) origin 
to the new equine host [33].
Conclusion
The study of NS1 sequences of three Moroccan strains 
shows that all mutations are not produced at the key 
residues of RBD (RNA-binding domain) and ED (effector 
domain) domains, and therefore do not appear to affect 
the potency of inhibition of cellular factor defences, and 
their virulence.
Abbreviations
BLAST: basic local alignment search tool; RT-PCR: reverse transcriptase-poly-
merase chain reaction; RBD: RNA-binding domain; ED: effector domain; NS: 
non-structural protein; NEP: nuclear export protein.
Authors’ contributions
The work presented here was carried out in collaboration between all authors. 
BM participated in the design of the study, carried out the molecular genetic 
studies, analysis and interpretation of data, the sequence alignment phyloge-
netic and drafted the manuscript. SA participated equitably in the molecular 
genetic studies and interpretation of data. MME, EHM, are conceived of the 
study and helped revising the manuscript. All authors read and approved the 
final manuscript.
Author details
1 Laboratory of Virology, Microbiology and Quality/ETB, Faculty of Sciences 
and Techniques, Mohammedia, University Hassan II Mohammedia-Casablanca, 
PO BOX 146, Quartier Yasmina, Mohammedia 20650, Morocco. 2 Department 
of Biology, Instruction Military Hospital Med V Rabat, University Mohammed V 
Souissi, Rabat, Morocco. 3 Society of Pharmaceutical and Veterinary Products, 
Virology Laboratory, Av Hassan II, BP 4569 Rabat, Morocco. 
Acknowledgements
This study was supported by the University Hassan II, Mohammedia-Casa-
blanca, Faculty of Sciences and Techniques, Mohammedia, Morocco. The 
authors thank the Inspection de Service de Santé Militaire/Division Vétérinaire 
staff for their support. Experimental and protocol designs were performed at 
the Laboratory of Virology, Microbiology and Quality/ETB (Faculty of Sciences 
and Technics, Mohammedia, University Hassan II Mohammadia-Casablanca). 
Strain isolations were performed at the Society of Pharmaceutical and Veteri-
nary Products, Virology Laboratory, Rabat, Morocco. NS gene sequencing was 
done at Functional Genomics Platform, Technical Support Unit for Scientific 
Research, CNRST, and Rabat, Morocco.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 24 February 2015   Accepted: 11 September 2015
Page 9 of 9Boukharta et al. BMC Res Notes  (2015) 8:471 
References
 1. Myers C, Wilson D. Equine Influenza Virus. Clin Tech Equine Pract. 
2006;5:187–96.
 2. Sovinova O, Tumova B, Pouska F, Nemec J. Isolation of a virus causing 
respiratory disease in horses. Acta Virol. 1958;2:52–61.
 3. Waddell GH, Teigland MB, Sigel MM. A new influenza virus associated 
with equine respiratory disease. J Am Vet Med Assoc. 1963;143:587–90.
 4. Timoney PJ. Equine influenza. Comp. lmmun MicrobioL infect Dis. 
1996;19:205–11.
 5. Barbic L, Madic J, Turk N, Daly J. Vaccine failure caused an outbreak of 
equine influenza in Croatia. Vet Microbiol. 2009;133:164–71.
 6. Lai ACK, Rogers KM, Glaser A, Tudor L, Chambers T. Alternate circulation 
of recent equine-2 influenza viruses (H3N8) from two distinct lineages in 
the United States. Virus Res. 2004;100:159–64.
 7. Burnouf T, Griffiths E, Padilla A, Seddik S, Stephano MA, Gutierrez JM. 
Assessment of the viral safety of antivenoms fractionated from equine 
plasma. Biologicals. 2004;32:115–28.
 8. Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, and 
Chen H. A single-amino-acid substitution in the NS1 protein changes 
the pathogenicity of H5N1 avian influenza viruses in mice. J Virol. 
2008;82:1146–54.
 9. Hale BG, Randall RE, Ortin G, Jackson D. The multifunctional NS1 protein 
of influenza A viruses. J Gen Virol. 2008;89:2359–76.
 10. Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, García-Sastre A, 
Saif YM, Lee CW. Characterization of influenza virus variants with different 
sizes of the Non-structural (NS) genes and their potential as a live influ-
enza vaccine in poultry. Vaccine. 2008;26:3580–6.
 11. Suarez DL, Perdue ML. Multiple alignment comparison of the non-struc-
tural genes of influenza A viruses. Virus Res. 1998;54:59–69.
 12. Quinlivan M, Zamarin D, Garcı´a-Sastre A, Cullinane A, Chambers T, Palese 
P. Attenuation of equine influenza viruses through truncations of the NS1 
protein. J Virol. 2005;79:8431–9.
 13. Na W, Kang B, Kim HI, Hong M, Park SJ, Jeoung HY, An DJ, Moon H, Kim 
JK, Song D. Isolation and genetic characterization of naturally NS-
truncated H3N8 equine influenza virus in South Korea. Epidemiol Infect. 
2014;142:759–66.
 14. Dundon WG, Capua I. A Closer look at the NS1 of influenza virus. Viruses. 
2009;1:1057–72.
 15. Dongzi L, Jingfang L, Zhizhen Z. Structure and function of the NS1 pro-
tein of influenza A virus. Acta Biochim Biophys Sin. 2007;39:155–62.
 16. Darapaneni V, Prabhaker VK, Kukol A. Large-scale analysis of influenza 
A virus sequences reveals potential drug target sites of non-structural 
proteins. J Gen Virol. 2009;90:2124–33.
 17. Kissi B, Daoudi N, El kantour A, Id sisi yahia K, Benazzou H. First isolation in 
the Morocco of the equine influenza virus called A/Equi/Morocco/1/97. 
Esp. Vét 1998; 14–10.
 18. Tissier O. Comparative study of sequences of the equine influenza virus 
isolated in French. Thesis submitted to the University Claude Bernard–
Lyon I (medicine–pharmacy) 2008. http://www2.vetagro-sup.fr/bib/
fondoc/th_sout/phpdrupal.php?annee=2008. Accessed 11 May 2015.
 19. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: molecular evolution-
ary genetics analysis (MEGA) software version 4.0. Mol Biol Evol. 
2007;24:1596–9.
 20. Martella V, Elia G, Decaro N, Di Trani L, Lorusso E, Campolo M, et al. An 
outbreak of equine influenza virus in vaccinated horses in Italy is due to 
an H3N8 strain closely related to recent North American representatives 
of the Florida sub-lineage. Vet Microbiol. 2007;121:56–63.
 21. Boukharta M, Touil N, El Fahim E, Terta M, Kissi B, Loutfi C, El Harrak M, 
Ennaji MM. Phylogenetic and molecular characterization of the equine 
influenza virus A (H3N8) causing the 1997 and 2004 outbreaks in 
Morocco. J Equine Vet Sci. 2013;34:942–8.
 22. Suarez DL, Perdue ML. Multiple alignment comparison of the non-struc-
tural genes of influenza A viruses. Virus Res. 1998;54:59–69.
 23. Parveen S, Asad UK. Structural and functional analysis of NS1 and NS2 
proteins of H1N1 subtype. Genom Proteom Bioinform. 2010;8:190–9.
 24. Yin C, Khan JA, Swapna GV, et al. Conserved surface features form the 
double-stranded RNA binding site of non-structural protein 1 (NS1) from 
influenza A and B viruses. J Biol Chem. 2007;282:20584–92.
 25. Marc D. NS1 influenza viruses: an influential protein. Virologie. 
2012;16:95–106.
 26. Burgui I, Aragon T, Ortın J, Nieto A. PABP1 and eIF4GI associate with 
influenza virus NS1 protein in viral mRNA translation initiation complexes. 
J Gen Virol. 2003;84:3263–74.
 27. Zohari S, Gyarmati P, Ejdersund A, Berglöf U, Thorén P, Ehrenberg M, Czifra 
G, Belák S, Waldenström J, Olsen B, Berg M. Phylogenetic analysis of the 
non-structural (NS) gene of influenza A viruses isolated from mallards in 
Northern Europe in 2005. Virol J. 2008;5:147.
 28. Greenspan D, Palese P, Krystal M. Two nuclear location signals in the 
influenza virus NS1 nonstructural protein. J Virol. 1988;62:3020–6.
 29. Tynell J, Melén K, Julkunen I. Mutations within the conserved NS1 nuclear 
export signal lead to inhibition of influenza A virus replication. Virol J. 
2014;11:1–12.
 30. Tombari W, Nsiri J, Larbi I, Guerin JC, Ghram A. Genetic evolution of low 
pathogenecity H9N2 Avian influenza viruses in Tunisia: acquisition of new 
mutations. Virol J. 2011;8:1–12.
 31. Munier S, Moisy D, Marc D, Naffakh N. Interspecies transmission, adapta-
tion to humans and pathogenicity of animal influenza viruses. Pathol Biol 
(Paris). 2010;58:59–68.
 32. Dea S, Elazhary MASY, Roy RS. The human and animals influenza virus. A 
review of the literature. Can Vet J. 1980;21:171–8.
 33. Bogoyavlenskiy A, Berezin V, Prilipov A, Korotetskiy I, Zaitseva I, Kydyr-
manov A, Karamedin K, Ishmukhametova N, Asanova S, Sayatov M, 
Zhumatov K. Phylogenetic analysis of the non-structural (NS) gene of 
influenza A viruses Isolated in Kazakhstan in 2002–2009. Virologica sinica. 
2011;26:376–85.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
